Are you a Health Professional? Jump over to the doctors only platform. Click Here


Print Friendly, PDF & Email

Generic Name: Zopiclone
Product Name: Imovane


Imovane is used to relief insomnia. It is used for short term treatment and is not recommended for use for more than 4 weeks at a time.


Imovane is a short acting hypnotic agent. It works by reducing the time taken to fall asleep, increasing the duration of sleep and decreasing the number of awakenings.

Dose advice

Dose Usage:

  • The standard adult dose of Imovane is one tablet just before you go to bed.
  • Do not drink alcohol before or after taking Imovane.
  • You should not operate dangerous machinery or drive motor vehicles after taking Imovane until you know how it affects you.
  • If you are over 65 years of age or have a liver problem, the dose is half a tablet to be taken just before you go to bed.
  • If you take Imovane on an empty stomach, it may work more quickly.
  • Imovane should only be used for short periods. Continuous long term use is not recommended unless advised by your doctor.


Imovane should not be used if you

  • have known allergy to active ingredient of Imovane, zopiclone or any other excipients
  • drink alcohol
  • have myasthenia gravis
  • have severe impairments of respiratory function
  • have acute cerebrovascular accident (CVA)
  • have sleep apnoea syndrome
  • have severe liver impairment
  • intend to give Imovane to children under 18 years


You must tell your doctor if you

  • are allergic to active ingredient of Imovane, zolpidem
  • are over 65 years old
  • intend to give it to children or adolscents
  • are pregnant or intend to become pregnant
  • are breastfeeding or planning to breastfeed
  • have liver problem, thyroid problems, depression and epilepsy
  • plan to have surgery
  • have sleep apnoea
  • if you have ever been addicted to alcohol or any drug or medicine
  • if you have ever suffered from a mental illness
  • if you are taking any other medicines, including those that you buy without a prescription from a pharmacy, supermarket or health food store

Use in pregnancy (Category C):

Imovane is not recommended to be used during pregnancy. Hence, you should avoid taking Imovane unless the benefits outweigh the risks.


The active ingredient of Imovane may be excreted into breast milk. Your doctor will discuss the risks of taking Imovane if you are breastfeeding or planning to breastfeed.


Imovane is Schedule 4.

Common side effects

All medicines have side effects. Most commonly the side effects are minor, however some can be more serious. Usually the benefits of taking a medication outweigh the associated side effects. Your doctor would have considered these side effects before starting you on Imovane.

Common side effects are those which occur in more than 1% of patients given Imovane. These include:

  • headaches
  • dry mouth
  • bitter taste in your mouth
  • drowsiness

If you experience any of the listed side effects, or any other symptoms which appear abnormal or unusual, please tell your doctor.

Uncommon side effects

Side effects which occur in less than 1% of patients given Imovane are considered uncommon. Patients do not necessarily experience any of these side effects, so do not become alarmed by this list:

  • heartburn
  • nausea, vomiting, diarrhoea
  • change in appetite
  • stomach pain
  • rash
  • agitation
  • depression
  • confusion
  • anxiety
  • dizziness
  • blurred vision
  • impotence
  • sleep walking or other behaviours whilst asleep

The following symptoms are rare (occurrence less than 0.1%) but very serious. If you have them, you may need urgent medical attention or hospitalisation.

  • swelling of the face, lips, mouth or throat
  • hives
  • fainting


  1. Australian Medicines Handbook. Zopiclone. January 2008 [cited 2008 September 11]. Available from: [URL Link]
  2. MIMS Online. Imovane. 01 May 2007 [cited 2008 September 11]. Available from: [URL Link]

For further information talk to your doctor.

Print Friendly, PDF & Email


Posted On: 22 July, 2003
Modified On: 5 October, 2008
Reviewed On: 11 September, 2008


Created by: myVMC